1-20 of 22
Andrew R. Rezvani, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma

Christopher Lemieux, MD, Juliana Craig, BA, David Iberri, MD, Sally Arai, MD MS, Laura J. Johnston, MD, Robert Lowsky, MD FRCP, Lori S. Muffly, MD MS, Parveen Shiraz, MD, Michaela Liedtke, MD, Andrew R. Rezvani, MD, Matthew J. Frank, MD PhD, Wen-Kai Weng, MD PhD, Everett H Meyer, MD PhD, Judith A Shizuru, MD PhD, Robert S. Negrin, MD, David B. Miklos, MD PhD, Surbhi Sidana, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-137091
Published: 2020
Journal Articles

Bleeding and Thrombosis Are Associated with Endothelial Dysfunction in CAR-T Cell Therapy and Are Increased in Patients Experiencing Neurologic Toxicity

Andrew Johnsrud, MD, Juliana Craig, BA, John H. Baird, MD, Jay Y. Spiegel, MDFRCPC, Lori S. Muffly, MD MS, James Zehnder, MD, Robert S. Negrin, MD, Laura J. Johnston, MD, Sally Arai, MD MS, Judith A Shizuru, MD PhD, Robert Lowsky, MD FRCP, Everett H Meyer, MD PhD, Wen-Kai Weng, MD PhD, Parveen Shiraz, MD, Andrew R. Rezvani, MD, Theresa Latchford, RN, Crystal L. Mackall, MD, David B. Miklos, MD PhD, Matthew J. Frank, MD PhD, Surbhi Sidana, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-142218
Published: 2020
Journal Articles

Outcomes after Second Allogeneic Transplantation and Donor Lymphocyte Infusion for Relapse after a First Allogeneic Transplant

Christopher Lemieux, MD, Lori S. Muffly, MD MS, Sally Arai, MD MS, Andrew R. Rezvani, MD, Surbhi Sidana, MD, Laura J. Johnston, MD, Wen-Kai Weng, MD PhD, Parveen Shiraz, MD, Matthew J. Frank, MD PhD, Everett H Meyer, MD PhD, Judith A Shizuru, MD PhD, David B. Miklos, MD PhD, Robert S. Negrin, MD, Robert Lowsky, MD FRCP
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-134250
Published: 2020
Journal Articles

Long-Term Outcomes of Patients with Peripheral T-Cell Lymphoma after Autologous Hematopoietic Cell Transplantation

Olivier Veilleux, MD, Francisco Socola, MD, Sally Arai, MD MS, Robert Lowsky, MD FRCP, Judith A Shizuru, MD PhD, Parveen Shiraz, MD, Lori S. Muffly, MD MS, Laura J. Johnston, MD, Matthew J. Frank, MD PhD, Surbhi Sidana, MD, Everett H Meyer, MD PhD, Andrew R. Rezvani, MD, David B. Miklos, MD PhD, Robert S. Negrin, MD, Wen-Kai Weng, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-136493
Published: 2020
Journal Articles

Monitoring Measurable Residual Disease Using Peripheral Blood in Acute Lymphoblastic Leukemia: Results of a Prospective, Observational Study

Lori S. Muffly, MD MS, Vandana Sundaram, MPH, Connie Chen, Ilana Yurkiewicz, MD BS, Eric Kuo, Sarah Burnash, Jay Y. Spiegel, MDFRCPC, Kelly Chyan, Sally Arai, MD MS, Matthew J. Frank, MD PhD, Laura J. Johnston, MD, Robert Lowsky, MD FRCP, Everett H Meyer, MD PhD, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Surbhi Sidana, MD, Parveen Shiraz, MD, Judith A Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Michaela Liedtke, MD, Hyma T. Vempaty, MD, David B. Miklos, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-138988
Published: 2020
Journal Articles

CD22-Directed CAR T-Cell Therapy Mediates Durable Complete Responses in Adults with Relapsed or Refractory Large B-Cell Lymphoma after Failure of CD19-Directed CAR T-Cell Therapy and High Response Rates in Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

John H. Baird, MD, Matthew J. Frank, MD PhD, Juliana Craig, BA, Shabnum Patel, PhD, Jay Y. Spiegel, MDFRCPC, Bita Sahaf, PhD, Sheren F. Younes, MD PhD, Jean S. Oak, MD PhD, Yasodha Natkunam, MD PhD, Zachary Ehlinger, MS, Warren D. Reynolds, BS, Sally Arai, MD MS, Laura J. Johnston, MD, Robert Lowsky, MD FRCP, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Parveen Shiraz, MD, Surbhi Sidana, MD, Wen-Kai Weng, MD PhD, Liora M. Schultz, MD, Sneha Ramakrishna, MD, Kara L Davis, DO, Steven A. Feldman, PhD, Crystal L. Mackall, MD, David B. Miklos, MD PhD, Lori S. Muffly, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-139087
Published: 2020
Journal Articles

Orca-T, a Precision Treg-Engineered Donor Product, Prevents Acute Gvhd with Less Immunosuppression in an Early Multicenter Experience with Myeloablative HLA-Matched Transplants

Everett H Meyer, MD PhD, Rasmus Hoeg, MD, Anna Moroz, MD PhD, Bryan Xei, BS, Hsin-Hsu Wu, MD, Rahul Pawar, Kartoosh Heydari, MD, David B. Miklos, MD PhD, Parveen Shiraz, MD, Lori S. Muffly, MD MS, Sally Arai, MD MS, Laura J. Johnston, MD, Robert Lowsky, MD FRCP, Andrew R. Rezvani, MD, Judith A Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Nathaniel Fernhoff, PhD, Gerhard Bauer, Arpita Gandhi, MD MS, Amy Putnam, J. Scott Scott McClellan, MDPhD, Bronwen E. Shaw, PhD MRCP, FRCPath, Joseph P. McGuirk, DO, Mehrdad Abedi, MD, Robert S. Negrin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 47–48.
https://doi.org/10.1182/blood-2020-142974
Published: 2020
Journal Articles

Survival Following Post-HCT Relapse in Adult Acute Lymphoblastic Leukemia Has Improved in the Era of Novel Immunotherapies: A Single Institution Analysis

Juliana Craig, BA, Maria Iglesias, BS, Kristen Cunanan, PhD, Sally Arai, MD MS, Matthew J. Frank, MD PhD, Laura J. Johnston, MD, Robert Lowsky, MD FRCP, Everett H Meyer, MD PhD, David B. Miklos, MD PhD, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Judith A Shizuru, MD PhD, Surbhi Sidana, MD, W-K Weng, MD PhD, Parveen Shiraz, MD, Lori S. Muffly, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–49.
https://doi.org/10.1182/blood-2020-141489
Published: 2020
Journal Articles

Improved Outcomes for Relapsed/Refractory Classic Hodgkin Lymphoma Following Autologous Stem Cell Transplantation in the Era of Novel Agents

R. Alejandro Sica, MD, Michael A Spinner, John S Tamaresis, PhD, Ranjana H Advani, MD, Laura J Johnston, MD, Robert Lowsky, MD, Everett H Meyer, MD PhD, David B Miklos, MD PhD, Lori S Muffly, MD, Andrew R Rezvani, MD, Judith A Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Robert S. Negrin, MD, Sally Arai, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2022.
https://doi.org/10.1182/blood-2019-131532
Published: 2019
Journal Articles

No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Compared to Conventional CBT: Results of a Randomized Trial

Filippo Milano, MD PhD, Andrew R Rezvani, MD, Joanne Kurtzberg, MD, Chatchada Karanes, MD, Jonathan A Gutman, MD, Christine Duncan, MD, Alla Keyzner, MD, Rabi Hanna, MD, Tonya Kimberly Marmon, PhD, Ann Dahlberg, MD, Colleen Delaney, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 146.
https://doi.org/10.1182/blood-2019-130716
Published: 2019
Journal Articles

Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort

Michael A Spinner, MD, Vanessa E Kennedy, MD, John S Tamaresis, PhD, Philip W Lavori, PhD, Linda V Elder, BA, Sally Arai, MD, Laura J Johnston, MD, Everett H Meyer, MD PhD, David B. Miklos, MD PhD, Lori S Muffly, MD, Robert S. Negrin, MD, Andrew R Rezvani, MD, Judith A Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Richard T Hoppe, MD, Samuel Strober, MD, Robert Lowsky, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4638.
https://doi.org/10.1182/blood-2018-99-113597
Published: 2018
Journal Articles

Elevated Axicabtagene Ciloleucel (CAR-19) Expansion By Immunophenotyping Is Associated with Toxicity in Diffuse Large B-Cell Lymphoma

Jay Y. Spiegel, MD, Bita Sahaf, PhD, Nasheed Hossain, MD, Matthew J. Frank, MD PhD, Gursharan Claire, MPH, Matthew Abramian, PhD, Theresa Latchford, RN, Bertha Villa, MPH, Juancarlos Cancilla, Jean Oak, MD PhD, Yasodha Natkunam, MD PhD, Steven R. Long, MD, Sally Arai, MD, Laura J Johnston, MD, Robert Lowsky, MD, Everett H Meyer, MD PhD, Lori S Muffly, MD, Robert S. Negrin, MD, Andrew R Rezvani, MD, Judith A Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Katherine A. Kong, Crystal L. Mackall, MD, David B. Miklos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 576.
https://doi.org/10.1182/blood-2018-99-113261
Published: 2018
Journal Articles

Consolidative CD8 + Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation

Michael A. Spinner, MD, Lori S. Muffly, MD MS, Sally Arai, MD, Laura Johnston, MD, Everett H. Meyer, MD PhD, David B. Miklos, MD PhD, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Judith A. Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Samuel Strober, MD, Robert Lowsky, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2003.
https://doi.org/10.1182/blood.V130.Suppl_1.2003.2003
Published: 2017
Journal Articles

Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors

Michael A. Spinner, MD, Marcelo Fernandez Vina, PhD, Linda Elder, BA, Sally Arai, MD, Laura Johnston, MD, Everett Meyer, MD PhD, David Miklos, MD PhD, Lori Muffly, MD, Robert S. Negrin, MD, Judith Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Ginna G. Laport, MD, Samuel Strober, MD, Robert Lowsky, MD, Andrew R. Rezvani, MD
Journal: Blood
Blood (2016) 128 (22): 4669.
https://doi.org/10.1182/blood.V128.22.4669.4669
Published: 2016
Journal Articles

Phase I Study of CD8 Memory T-Cell Donor Lymphocyte Infusion for Relapse of Hematologic Malignancies Following Matched Related Donor Allogeneic Hematopoietic Cell Transplantation

Lori S. Muffly, MDMS, Kevin Sheehan, PhD, Randall Armstrong, Keri Tate, PhD, Cynthia Tudisco, Andrew R. Rezvani, MD, David Miklos, MD PhD, Sally Arai, MD, Judith Shizuru, MD PhD, Laura Johnston, Everett Meyer, MD PhD, Wen-Kai Weng, MD PhD, Ginna G. Laport, MD, Robert S Negrin, MD, Sam Strober, Robert Lowsky, MD
Journal: Blood
Blood (2016) 128 (22): 4615.
https://doi.org/10.1182/blood.V128.22.4615.4615
Published: 2016
Journal Articles

Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms

Rupa Narayan, MD, Jonathan Benjamin, MD PhD, Ginna Laport, MD, Lu Tian, PhD, Keri Tate, PhD, Linda Elder, Leah Galvez, RN, Randall Armstrong, Kevin Sheehan, PhD, Robert Lowsky, MD, Sally Arai, MD, Laura Johnston, MD, David Miklos, MD PhD, Lori S. Muffly, MD, Andrew R. Rezvani, MD, Judith Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Samuel Strober, MD, Robert Negrin, MD, Everett Meyer, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3232.
https://doi.org/10.1182/blood.V126.23.3232.3232
Published: 2015
Journal Articles

Molecular Remission One Year Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia Predicts Relapse-Free and Overall Survival: A Multi-Institutional Landmark Analysis

Aaron C. Logan, MDPhD, Alex F. Herrera, MD, Christine E. Ryan, Andrew R. Rezvani, MD, Katherine A. Kong, PhD, Malek Faham, MD PhD, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Rachel L. Sargent, MD, Edwin P. Alyea, MD, Vincent T. Ho, MD, Jennifer R. Brown, MD PhD, Jerome Ritz, MD, David B. Miklos, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4340.
https://doi.org/10.1182/blood.V126.23.4340.4340
Published: 2015
Journal Articles

Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis

Michael P. Chu, MD, Joshua Brody, MD, Holbrook E Kohrt, MD PhD, Matthew J. Frank, MD PhD, Michael Khodadoust, MD PhD, Sunil Reddy, MD, Ranjana H Advani, MD, Neel K. Gupta, MD, Ginna Laport, MD, Lauren S Maeda, MD, Everett Meyer, MD PhD, David B. Miklos, MD PhD, Robert Negrin, MD, Andrew R. Rezvani, MD, Wen-Kai Weng, MD PhD, Kevin Sheehan, PhD, Malek Faham, MD PhD, Debra K Czerwinski, Ami Okada, PhD, Ronald Levy, MD
Journal: Blood
Blood (2015) 126 (23): 1536.
https://doi.org/10.1182/blood.V126.23.1536.1536
Published: 2015
Journal Articles

Low Toxicity and Mortality with Reversed-Order Conditioning (Cyclophosphamide Followed by Targeted Intravenous Busulfan) in Allogeneic Hematopoietic Cell Transplantation: Preliminary Results of a Prospective Clinical Trial.

Andrew R. Rezvani, MD, Jeannine S. McCune, PhD, Ami Batchelder, Barry E. Storer, PhD, George B. McDonald, MD, H. Joachim Deeg, MD
Journal: Blood
Blood (2009) 114 (22): 1175.
https://doi.org/10.1182/blood.V114.22.1175.1175
Published: 2009
Journal Articles

Falling Serum Albumin Predicts Severity of Acute Graft-Vs.-Host Disease and Non-Relapse Mortality After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation.

Andrew R. Rezvani, MD, Barry E. Storer, PhD, Rainer F. Storb, MD, Marco Mielcarek, MD, David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Paul J. Martin, MD, Mary E. D. Flowers, MD, George B. McDonald, MD
Journal: Blood
Blood (2009) 114 (22): 1146.
https://doi.org/10.1182/blood.V114.22.1146.1146
Published: 2009